​

Arcutis Biotherapeutics Ownership | Who Owns Arcutis Biotherapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Arcutis Biotherapeutics Ownership Summary

Arcutis Biotherapeutics is owned by 103.37% institutional investors, 2.15% insiders. Jennison associates is the largest institutional shareholder, holding 9.37% of ARQT shares. Polar Capital Biotech S Inc is the top mutual fund, with 5.13% of its assets in Arcutis Biotherapeutics shares.

ARQT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockArcutis Biotherapeutics103.37%2.15%-5.52%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jennison associates11.57M9.37%$107.62M
Suvretta capital management10.00M8.10%$93.04M
Rubric capital management lp9.82M7.95%$91.30M
Blackrock8.62M7.76%$80.19M
Frazier life sciences management8.79M7.11%$81.70M
Polar capital6.88M5.57%$63.98M
Vanguard group6.14M5.53%$57.14M
State street5.13M4.62%$47.75M
Franklin resources4.44M3.59%$41.28M
Morgan stanley3.97M3.22%$36.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor2.04M14.59%$18.98M
Tejara capital1.34M4.54%$12.50M
Frazier life sciences management8.79M3.82%$81.70M
Suvretta capital management10.00M3.42%$93.04M
Rubric capital management lp9.82M2.39%$91.30M
Cormorant asset management, lp2.52M1.36%$23.48M
Two seas capital lp762.19K1.15%$7.09M
Eversept partners, lp837.85K0.53%$7.79M
Gilder gagnon howe3.62M0.42%$33.63M
Polar capital6.88M0.38%$63.98M

Top Buyers

HolderShares% AssetsChange
Rubric capital management lp9.82M2.39%2.31M
Suvretta capital management10.00M3.42%2.13M
Blackrock8.62M0.00%1.96M
Candriam s.c.a.1.31M0.07%1.31M
Vanguard group6.14M0.00%977.87K

Top Sellers

HolderShares% AssetsChange
State street5.13M0.00%-3.65M
Farallon capital management26.00K0.00%-1.75M
Braidwell lp---1.30M
Bain capital life sciences investors---1.03M
Ensign peak advisors2.13M0.04%-846.64K

New Positions

HolderShares% AssetsChangeValue
Candriam s.c.a.1.31M0.07%1.31M$12.16M
Eversept partners, lp837.85K0.53%837.85K$7.79M
Lazard asset management360.00K0.00%360.00K$3.35M
Ubs asset management americas273.78K0.00%273.78K$2.55M
Swiss national bank203.60K0.00%203.60K$1.89M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-22.00
Mather group, llc.-190.00
Optiver b.v.-398.00
Macroview investment management-875.00
Pacer advisors-1.48K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241941.57%128,485,4751.57%1030.98%104-3.70%51-7.27%
Jun 30, 202419113.02%126,499,0251.37%1020.81%108-0.92%5544.74%
Mar 31, 202416924.26%124,792,42623.24%1120.94%10921.11%3846.15%
Dec 31, 2023136-4.23%101,262,58151.01%1090.93%9025.00%26-27.78%
Sep 30, 2023142-3.40%67,057,731-6.97%1080.79%72-24.21%3633.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Polar Capital Biotech S Inc6.00M5.13%-
Vanguard Total Stock Mkt Idx Inv3.52M3.01%-68.84K
Jennison SMid Cap Core Equity3.09M2.64%-
PGIM Jennison Small Company A3.09M2.64%-
SPDR® S&P Biotech ETF3.05M2.61%33.79K
iShares Russell 2000 ETF2.75M2.35%-6.17K
Jennison Health Sciences Equity2.74M2.34%-
PGIM Jennison Health Sciences Z2.74M2.34%-
Franklin Biotechnology Discv A(acc)USD2.66M2.27%-
Vanguard Institutional Extnd Mkt Idx Tr1.60M1.37%-4.63K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 30, 2024Edwards Larry Todd See RemarksBuy$7.77K
Nov 30, 2024Matsuda Masaru See RemarksBuy$11.77K
May 31, 2024Matsuda Masaru See RemarksBuy$6.77K
Dec 02, 2024Welgus Howard G.-Sell$125.13K
Nov 30, 2024Watanabe Todd Franklin See RemarksBuy$14.48K

Insider Transactions Trends

DateBuySell
2024 Q4312
2024 Q3-9
2024 Q2-10
2024 Q116
2023 Q411

ARQT Ownership FAQ

Who Owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics shareholders are primarily institutional investors at 103.37%, followed by 2.15% insiders and -5.52% retail investors. The average institutional ownership in Arcutis Biotherapeutics's industry, Biotech Stocks , is 47.04%, which Arcutis Biotherapeutics exceeds.

Who owns the most shares of Arcutis Biotherapeutics?

Arcutis Biotherapeutics’s largest shareholders are Jennison associates (11.57M shares, 9.37%), Suvretta capital management (10M shares, 8.10%), and Rubric capital management lp (9.82M shares, 7.95%). Together, they hold 25.42% of Arcutis Biotherapeutics’s total shares outstanding.

Does Blackrock own Arcutis Biotherapeutics?

Yes, BlackRock owns 7.76% of Arcutis Biotherapeutics, totaling 8.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 80.19M$. In the last quarter, BlackRock increased its holdings by 1.96M shares, a 29.49% change.

Who is Arcutis Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Arcutis Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 14.59% of its assets in 2.04M Arcutis Biotherapeutics shares, valued at 18.98M$.

Who is the top mutual fund holder of Arcutis Biotherapeutics shares?

Polar Capital Biotech S Inc is the top mutual fund holder of Arcutis Biotherapeutics shares, with 5.13% of its total shares outstanding invested in 6M Arcutis Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools